India-based online Ayurveda consultancy platform NirogStreet raises USD 4 million in Series B

NirogStreet, an online platform for Ayurveda doctor consultancy, raised USD 4 million in a Series B funding round from UAE-based CE Ventures, Japan’s ICMG Partners and others on 24 December 2021.

Investors: In addition to UAE-based CE Ventures and Japan’s ICMG Partners, the funding round also saw participation from Gokul Rajaram, board member at Coinbase and Pinterest; Wavemaker partners, Samir Kumar; Anuj Srivastava, Founder at Livspace; Rajeev Kannan, Management Executive officer at Sumitomo, Singapore; Suresh Vasudevan, CEO of Sysdig USA; Ramakant Sharma, Co-founder of Livspace, Andy Hwang, Ex-Google Executive, Ashutosh Sinha, former CEO at Morgan Stanley, Dr. Kyohei Takano, a Tokyo based Gynecologist, Arup Dutta, VP of Global Quantitative Equity at Mackenzine Investments and Lalit Mittal, Head, Livspace Interior Business.

The Objectives behind the funding: The company plans to deploy the current proceeds to strengthen operations and for service and product offerings.

About NirogStreet

Founded in June 2016 by Ram N Kumar, Abhishek Gupta, Anirudha Mohite and Shrey Jain, NirogStreet is a digital healthcare platform designed to provide access to authentic ayurvedic doctors on a global scale. The startup’s platform provides an online community that enables patients to review doctors and encourages them to create and publish case studies and research reports to bring in evidence-based treatment similar to modern medicine, permitting patients to get the correct adoption of pure Ayurveda in management and prevention of ailments. The company strives to make Ayurveda the first call of treatment for people.

What the Founder has to say:

“We are confident that our continuous efforts in mainstreaming Ayurveda have started mainstream conversations, rebuilt perceptions and reassured on the fact that this most effective and ancient medicine science is a gift from India for the world,” said Ram N Kumar, Founder & CEO of NirogStreet.

What the Investors have to say:

Tushar Singhvi, Deputy CEO and Head of Investments, Crescent Enterprises, commented, “We are excited to embark on this journey with Nirogstreet. The company has demonstrated the immense value and opportunity within the Ayurveda market, which is projected to reach $9.5 billion by 2024, as well as the limitless possibilities that tech-enabled solutions can offer.

Gen Funahashi, CEO at Japan Based Venture Capital, ICMG Partners, said, “NirogStreet is not just a simple Ayurveda E-commerce platform; it brings much more value to the industry than that. I believe that NirogStreet directly addresses many shortcomings of the current Ayurveda industry.”

For more extensive analysis and Market Intelligence reports feel free to approach us or visit our website: Venture Capital Market Intelligence Reports | VCBay.

We try our best to fact check and bring the best, well-researched and non-plagiarized content to you. Please let us know

-if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!

Next Article